ResearcherShanghai Medical College of Fudan UniversityNo recent work listed

C Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5034295304. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of patients with advanced pancreatic cance… Last author DOI 10.1016/j.ejso.2017.07.010 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Cheng He · 1 shared paper, 2017 · strength 0.07
- Paper The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of… DOI 10.1016/j.ejso.2017.07.010 ↗
Meng Guo · 1 shared paper, 2017 · strength 0.07
- Paper The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of… DOI 10.1016/j.ejso.2017.07.010 ↗
Chunyan Yang · 1 shared paper, 2017 · strength 0.07
- Paper The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of… DOI 10.1016/j.ejso.2017.07.010 ↗
Xianjun Yu · 1 shared paper, 2017 · strength 0.07
- Paper The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of… DOI 10.1016/j.ejso.2017.07.010 ↗
Guopei Luo · 1 shared paper, 2017 · strength 0.07
- Paper The metastasis status and tumor burden-associated CA125 level combined with the CD4/CD8 ratio predicts the prognosis of… DOI 10.1016/j.ejso.2017.07.010 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.